此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

急性前循环血栓切除术患者预防性使用应激性溃疡药物与临床结果的关系

急性前循环血栓切除术患者预防性使用应激性溃疡药物与临床结果的关联:一项前瞻性、多中心、观察性队列研究

Ischemic stroke accounts for a relatively high proportion of strokes. In recent years, intravenous thrombolysis and endovascular therapy have significantly improved the revascularization rate in patients with large vessel occlusive cerebral infarction, but 20-50% of patients still experience ineffective revascularization. Therefore, postoperative monitoring and treatment of patients with large vessel occlusions is crucial for early recognition, management and prevention of complications. Stress ulcer bleeding is a serious complication after acute ischemic stroke, with a prevalence of 1%-5%, and a previously proven incidence of stress ulcer bleeding after ischemic stroke. Stress ulcer bleeding after ischemic stroke has been shown to be closely associated with unfavorable outcomes, such as mortality. Current national and international guidelines or consensus on the prevention of stress ulcers after acute ischemic stroke do not advocate the routine use of histamine receptor antagonists or proton pump inhibitors for the prevention of stress ulcers, but rather should be considered in the context of the patient's risk factors for stress ulcers and discontinued after the patient initiates enteral nutrition. However, there is no evidence-based medical evidence to support the risk-benefit relationship of stress ulcer drug prophylaxis in patients with mechanical thrombectomy for acute anterior circulation large vessel occlusion.

研究概览

地位

招聘中

详细说明

Stress ulcer bleeding is a serious complication after acute ischemic stroke, with a prevalence of 1%-5%, of which only 0.5%-1% require blood transfusion or result in hypotension. Stress ulcer bleeding after ischemic stroke has been shown to be associated with poor outcomes, such as mortality, and basilar artery occlusion and middle cerebral artery cerebral infarction are independent risk factors for stress ulcer bleeding after acute ischemic stroke. Guidelines or consensus on the prevention of stress ulcers after acute ischemic stroke do not advocate the routine use of histamine receptor antagonists or proton pump inhibitors for stress ulcer prevention.

However, stress ulcer prophylaxis is initiated in most patients admitted to the neurological intensive care unit after mechanical embolization of acute anterior circulation large vessel occlusion. With advances such as diagnosis and early initiation of enteral nutrition, the rate of stress ulcer bleeding in patients with mechanical embolization of acute anterior circulation large vessel occlusion is significantly reduced. The relationship between the risk and benefit of SUP in patients undergoing mechanical embolization for acute anterior circulation large vessel occlusion is not yet supported by evidence-based medical evidence. Therefore, the purpose of this study was to investigate the correlation between pharmacological stress ulcer prophylaxis and clinical outcomes in patients undergoing mechanical thrombectomy for acute anterior circulation large vessel occlusion.

研究类型

观察性的

注册 (估计的)

2592

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

    • Fujian
      • Fuzhou、Fujian、中国
        • 招聘中
        • Fujian Medical University Union Hospital
        • 接触:
          • Shenggen Chen, M.D.
          • 电话号码:13459480275
    • Guangdong
      • Dongguan、Guangdong、中国
        • 招聘中
        • Dongguan People's Hospital
        • 接触:
          • Zhu Shi, M.D.
          • 电话号码:13669825459
      • Dongguan、Guangdong、中国
        • 招聘中
        • Dongguan donghua hospital
        • 接触:
          • Lingyu Sun
          • 电话号码:13829203368
      • Guangzhou、Guangdong、中国
        • 招聘中
        • Nanfang Hospital of Southern Medical University
        • 接触:
          • Suyue Pan
          • 电话号码:13556184981
      • Guangzhou、Guangdong、中国
        • 招聘中
        • Guangdong Provincial Hospital of Traditional Chinese Medicine
        • 接触:
          • Lixin Wang, M.D.
          • 电话号码:13922793886
      • Guangzhou、Guangdong、中国
        • 招聘中
        • Huadu District People's Hospital of Guangzhou
        • 接触:
          • Guangning Li, M.D.
          • 电话号码:13926239656
      • Guangzhou、Guangdong、中国
        • 招聘中
        • The Fourth Affiliated Hospital of Guangzhou Medical University
        • 接触:
          • Wangchi Luo, M.D.
          • 电话号码:13710895142
      • Heyuan、Guangdong、中国
        • 招聘中
        • Heyuan people's Hospital
        • 接触:
          • Minzhen Zhu
          • 电话号码:15007622318
      • Huizhou、Guangdong、中国
        • 招聘中
        • Huizhou Municipal Central Hospital
        • 接触:
          • Lizhi Wang, M.D.
          • 电话号码:13802872076
    • Hainan
      • Haikou、Hainan、中国
        • 招聘中
        • Hainan Provincial People's Hospital
        • 接触:
          • Fan Zhang, M.D.
          • 电话号码:17389897580
      • Haikou、Hainan、中国
        • 招聘中
        • Haikou People's Hospital
        • 接触:
          • Guoshuai Yang, M.D.
          • 电话号码:13876006248
      • Haikou、Hainan、中国
        • 招聘中
        • Hainan Traditional Chinese Medicine Hospital
        • 接触:
          • Yong Gu, M.D.
          • 电话号码:15521280288
    • Hunan
      • Changsha、Hunan、中国
        • 招聘中
        • The First Hospital of Changsha
        • 接触:
          • Xu Peng, M.D。
          • 电话号码:15802507292
      • Hengyang、Hunan、中国
        • 招聘中
        • The Second Hospital University of South China
        • 接触:
          • Yanhong Hu, M.D.
          • 电话号码:13265004191
      • Yueyang、Hunan、中国
        • 招聘中
        • Yueyang People's Hospital
        • 接触:
          • Yuan Zhou, M.D.
          • 电话号码:15107309796
    • Inner Mongolia
      • Baotou、Inner Mongolia、中国
        • 招聘中
        • Sinopharm North Hospital
        • 接触:
          • Lifei Xing, M.D
          • 电话号码:15354919958
      • Hohhot、Inner Mongolia、中国
        • 招聘中
        • The Affiliated Hospital of Inner Mongolia Medical University
        • 接触:
          • Lihua Sun, M.D.
          • 电话号码:18686292585
    • Jiangxi
      • Ganzhou、Jiangxi、中国
        • 招聘中
        • Ganzhou City People's Hospital
        • 接触:
          • Zhaohui Lai
          • 电话号码:13879729792
    • Zhejiang
      • Wenzhou、Zhejiang、中国
        • 招聘中
        • Second Affiliated Hospital of Wenzhou Medical University
        • 接触:
          • Saijun Zhou, M.D.
          • 电话号码:13857746659

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

概率样本

研究人群

Patients who are treated with mechanical thrombectomy with acute anterior circulation large vessel occlusion. ≥18 years of age, within 24 hours of onset. Expected survival >3 months. NIHSS score ≥ 6 at onset of illness.

描述

Inclusion Criteria:

  1. Age ≥18 years.
  2. Within 24 hours of onset. Meet the criteria for diagnosis of acute ischemic stroke in the "China Acute Ischemic Stroke Diagnosis and Treatment Guidelines 2018".
  3. Meet the indications for mechanical thrombectomy in the "Chinese Guidelines for Early Endovascular Interventions in Acute Ischemic Stroke 2022".
  4. Treated with mechanical thrombectomy.
  5. NIHSS score ≥ 6 at onset of illness.
  6. Sign an informed notice.

Exclusion Criteria:

Allergy to drug ingredients. Women who are pregnant or breastfeeding. Life expectancy of less than 3 months due to other non-ischemic stroke diseases such as malignancy, severe liver or renal failure.

Have participated in other interventional clinical studies (affecting the outcome of this cohort study).

Participants who were judged by the investigator to be unsuitable for participation in this study.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:COHORT
  • 时间观点:PROSPECTIVE

队列和干预

团体/队列
Stress Ulcer Prophylaxis

Subjects are on stress ulcer medications including PPIs, H2RBs, and mucosal protectors at 24 h of admission.

Control Group

Subjects are not on stress ulcer medications including PPIs, H2RBs, and mucosal protectors at 24 h of admission.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
90-day mortality after onset
大体时间:90-day after onset

Proportion of enrolled patients who died 90 days after onset of disease.

90-day after onset
Incidence of stroke-associated pneumonia
大体时间:within 7-day of onset

Incidence of non-mechanically ventilated stroke patients with new pneumonia within 7-day of onset

within 7-day of onset

次要结果测量

结果测量
措施说明
大体时间
Incidence of clinically significant bleeding
大体时间:within 7-day of onset

One of the following 4 symptoms occurs within 24 hours of bleeding from a stress ulcer (in the absence of other causes):1. A decrease of ≥ 20 mmHg in any one of systolic, diastolic and mean arterial pressure. 2.Initiation of blood pressure boosters or 20% increase in medication dose.3. Decreased hemoglobin ≥ 2 g/d((1.24 mmol/l). 4.Infusion of erythrocytes ≥ 2 U.

within 7-day of onset
Incidence of stress ulcer bleeding
大体时间:7-day after onset

Coffee-like residue/black stool/blood in stool within 7-day after onset and more than 2 consecutive positive fecal/gastric fluid occult blood

7-day after onset
Incidence of unfavorable functional prognosis at 90 days after onset
大体时间:90-day after onset

Incidence of unfavorable functional prognosis at 90 days after onset

90-day after onset
90-day mRS score change
大体时间:90-day after onset

Modified Rankin Scale score change within 90 days after onset in patients who were eligible for inclusion criteria

90-day after onset
Incidence of early neurological deterioration
大体时间:within 72 hours after onset

Increased score of National Institutes of Health Stroke Scale within 72h after onset ≥ 4

within 72 hours after onset
1-year post-onset mortality
大体时间:1 year after onset

Mortality at 1 year after onset in patients who were eligible for inclusion criteria

1 year after onset
Incidence of adverse related events such as pneumonia or myocardial ischemia 1 year after onset
大体时间:1 year after onset

Incidence of adverse related events such as pneumonia or myocardial ischemia 1 year after onset in patients who were eligible for inclusion criteria

1 year after onset

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2023年5月1日

初级完成 (实际的)

2026年8月1日

研究完成 (估计的)

2027年5月1日

研究注册日期

首次提交

2023年4月26日

首先提交符合 QC 标准的

2023年4月26日

首次发布 (实际的)

2023年5月6日

研究记录更新

最后更新发布 (实际的)

2026年11月5日

上次提交的符合 QC 标准的更新

2026年11月2日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅